Anti-IL-17 mAbs herald new options in psoriasis

Nat Biotechnol. 2012 Jun 7;30(6):475-7. doi: 10.1038/nbt0612-475.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / drug therapy
  • Clinical Trials as Topic
  • Drug Industry
  • Humans
  • Interleukin-17 / antagonists & inhibitors*
  • Interleukin-17 / immunology*
  • Psoriasis / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-17
  • brodalumab